Trial intelligence / Profile preview

Pharmacokinetics of single-dose intravenous esketamine in Chinese pediatric patients

ChiCTR2000039529Phase 4Recruiting

Sponsor
Xiamen Maternal and Child Health Care Hospital
Start
Dec 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of esketamine, sponsored by Xiamen Maternal and Child Health Care Hospital. Primary endpoints: Plasma concentration of esketamine and Plasma concentration of S-demethyl ketamine. Started Dec 2020; status: recruiting.

02

Drugs

esketamine

Beyond the preview

Go deeper on ChiCTR2000039529.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2000039529.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call